Year-end Sale % OFF 
Abstract
The Arg-Gly-Asp (RGD) tripeptide is the smallest recognition sequence for the α<sub>v</sub>β<sub>3</sub> integrin receptor. A number of nonpeptide analogues of the RGD linear sequence, some of them having improved pharmacological properties, have been proposed in the last two decades. In this study, the stereogenic trifluoroethylamine function was employed as peptide bond surrogate for the development of a new class of RGD peptide mimics. In fact, the trifluoroethylamine group was shown to behave as a peptide-bond surrogate maintaining the H-bond donor capacity of the NH peptide group and a CH(CF<sub>3</sub>)NH backbone angle close to the native peptide bond 120°. The trifluoroethylamine function is also known to display high metabolic stability and in some cases it positively affects ligand–receptor interactions. Two linear Ψ[CH(CF<sub>3</sub>)NH]Gly-RGD diastereoisomers were synthesized with good stereocontrol and submitted to biological assays. A remarkable loss in α<sub>v</sub>β<sub>3</sub> integrin affinity was observed for both compounds, suggesting that the bulky CF<sub>3</sub> moiety is not well tolerated within the α<sub>v</sub>β<sub>3</sub> binding pocket.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
